214 related articles for article (PubMed ID: 29370558)
21. miR-542-3p suppresses invasion and metastasis by targeting the proto-oncogene serine/threonine protein kinase, PIM1, in melanoma.
Rang Z; Yang G; Wang YW; Cui F
Biochem Biophys Res Commun; 2016 May; 474(2):315-320. PubMed ID: 27107696
[TBL] [Abstract][Full Text] [Related]
22. Roles of Pin1 as a Key Molecule for EMT Induction by Activation of STAT3 and NF-κB in Human Gallbladder Cancer.
Nakada S; Kuboki S; Nojima H; Yoshitomi H; Furukawa K; Takayashiki T; Takano S; Miyazaki M; Ohtsuka M
Ann Surg Oncol; 2019 Mar; 26(3):907-917. PubMed ID: 30610554
[TBL] [Abstract][Full Text] [Related]
23. A novel regulatory mechanism of Pim-3 kinase stability and its involvement in pancreatic cancer progression.
Zhang F; Liu B; Wang Z; Yu XJ; Ni QX; Yang WT; Mukaida N; Li YY
Mol Cancer Res; 2013 Dec; 11(12):1508-20. PubMed ID: 24165482
[TBL] [Abstract][Full Text] [Related]
24. Dihydroartemisinin inhibits melanoma by regulating CTL/Treg anti-tumor immunity and STAT3-mediated apoptosis via IL-10 dependent manner.
Yu R; Jin L; Li F; Fujimoto M; Wei Q; Lin Z; Ren X; Jin Q; Li H; Meng F; Jin G
J Dermatol Sci; 2020 Sep; 99(3):193-202. PubMed ID: 32859456
[TBL] [Abstract][Full Text] [Related]
25. The serine/threonine kinase Pim-2 is a novel anti-apoptotic mediator in myeloma cells.
Asano J; Nakano A; Oda A; Amou H; Hiasa M; Takeuchi K; Miki H; Nakamura S; Harada T; Fujii S; Kagawa K; Endo I; Yata K; Sakai A; Ozaki S; Matsumoto T; Abe M
Leukemia; 2011 Jul; 25(7):1182-8. PubMed ID: 21475253
[TBL] [Abstract][Full Text] [Related]
26. Galangin inhibits tumor growth and metastasis of B16F10 melanoma.
Zhang W; Tang B; Huang Q; Hua Z
J Cell Biochem; 2013 Jan; 114(1):152-61. PubMed ID: 22887049
[TBL] [Abstract][Full Text] [Related]
27. Effect of downregulation of ZEB1 on vimentin expression, tumour migration and tumourigenicity of melanoma B16F10 cells and CSCs.
Dou J; He X; Liu Y; Wang Y; Zhao F; Wang X; Chen D; Shi F; Wang J
Cell Biol Int; 2014 Apr; 38(4):452-61. PubMed ID: 24339410
[TBL] [Abstract][Full Text] [Related]
28. BENC-511, a novel PI3K inhibitor, suppresses metastasis of non-small cell lung cancer cells by modulating β-catenin/ZEB1 regulatory loop.
Zhang Q; Zhou L; Guan Y; Cheng Y; Han X
Chem Biol Interact; 2018 Oct; 294():18-27. PubMed ID: 30125547
[TBL] [Abstract][Full Text] [Related]
29. SOX2 Promotes the Epithelial to Mesenchymal Transition of Esophageal Squamous Cells by Modulating Slug Expression through the Activation of STAT3/HIF-α Signaling.
Gao H; Teng C; Huang W; Peng J; Wang C
Int J Mol Sci; 2015 Sep; 16(9):21643-57. PubMed ID: 26370982
[TBL] [Abstract][Full Text] [Related]
30. STAT3 regulates hypoxia-induced epithelial mesenchymal transition in oesophageal squamous cell cancer.
Cui Y; Li YY; Li J; Zhang HY; Wang F; Bai X; Li SS
Oncol Rep; 2016 Jul; 36(1):108-16. PubMed ID: 27220595
[TBL] [Abstract][Full Text] [Related]
31. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
[No Abstract] [Full Text] [Related]
32. A ROS/STAT3/HIF-1α signaling cascade mediates EGF-induced TWIST1 expression and prostate cancer cell invasion.
Cho KH; Choi MJ; Jeong KJ; Kim JJ; Hwang MH; Shin SC; Park CG; Lee HY
Prostate; 2014 May; 74(5):528-36. PubMed ID: 24435707
[TBL] [Abstract][Full Text] [Related]
33. Upregulation of MEK5 by Stat3 promotes breast cancer cell invasion and metastasis.
Liu F; Zhang H; Song H
Oncol Rep; 2017 Jan; 37(1):83-90. PubMed ID: 27878304
[TBL] [Abstract][Full Text] [Related]
34. Immunotherapy for hepatoma using a dual-function vector with both immunostimulatory and pim-3-silencing effects.
Guo Q; Lan P; Yu X; Han Q; Zhang J; Tian Z; Zhang C
Mol Cancer Ther; 2014 Jun; 13(6):1503-13. PubMed ID: 24723452
[TBL] [Abstract][Full Text] [Related]
35. Over-expression of lipocalin 2 promotes cell migration and invasion through activating ERK signaling to increase SLUG expression in prostate cancer.
Ding G; Fang J; Tong S; Qu L; Jiang H; Ding Q; Liu J
Prostate; 2015 Jun; 75(9):957-68. PubMed ID: 25728945
[TBL] [Abstract][Full Text] [Related]
36. Endoplasmic reticulum resident oxidase ERO1-Lalpha promotes hepatocellular carcinoma metastasis and angiogenesis through the S1PR1/STAT3/VEGF-A pathway.
Yang S; Yang C; Yu F; Ding W; Hu Y; Cheng F; Zhang F; Guan B; Wang X; Lu L; Rao J
Cell Death Dis; 2018 Oct; 9(11):1105. PubMed ID: 30377291
[TBL] [Abstract][Full Text] [Related]
37. Repurposing of the anti-helminthic drug niclosamide to treat melanoma and pulmonary metastasis via the STAT3 signaling pathway.
Zhu Y; Zuo W; Chen L; Bian S; Jing J; Gan C; Wu X; Liu H; Su X; Hu W; Guo Y; Wang Y; Ye T
Biochem Pharmacol; 2019 Nov; 169():113610. PubMed ID: 31465777
[TBL] [Abstract][Full Text] [Related]
38. N-myc downstream-regulated gene 2 (NDRG2) suppresses the epithelial-mesenchymal transition (EMT) in breast cancer cells via STAT3/Snail signaling.
Kim MJ; Lim J; Yang Y; Lee MS; Lim JS
Cancer Lett; 2014 Nov; 354(1):33-42. PubMed ID: 25153349
[TBL] [Abstract][Full Text] [Related]
39. AZD1208, a Pan-Pim Kinase Inhibitor, Has Anti-Growth Effect on 93T449 Human Liposarcoma Cells via Control of the Expression and Phosphorylation of Pim-3, mTOR, 4EBP-1, S6, STAT-3 and AMPK.
Yadav AK; Kumar V; Bailey DB; Jang BC
Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30654529
[TBL] [Abstract][Full Text] [Related]
40. NANOG regulates epithelial-mesenchymal transition and chemoresistance through activation of the STAT3 pathway in epithelial ovarian cancer.
Liu S; Sun J; Cai B; Xi X; Yang L; Zhang Z; Feng Y; Sun Y
Tumour Biol; 2016 Jul; 37(7):9671-80. PubMed ID: 26801672
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
